Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Tower (TWR) / HY25

Tower PBT margin hits unprecedented 23.7% as ROE reaches 29.0%

Reported NPAT rose 38.1% to NZ$49.7m but underlying NPAT of NZ$61.7m flags customer remediation and Canterbury claim drag.

Financials / Insurance

TWR revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY26 was $291.2m, versus $594.3m in FY25.

TWR EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
FY23 was -1.6%, versus 5.4% in FY22.

TWR operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY26 was $33m, versus $143.8m in FY25.

TWR working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
HY26 was $0m, versus $0m in FY25.
Release date
20 May 2025
Published
23 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

HY25 vs HY24

Revenue

$295.8m

+9.8% ↑ vs $269.4m

Net profit after tax

$49.7m

+38.1% ↑ vs $36m

Net cash inflow from operating activities

$57.7m

+63.2% ↑ vs $35.3m

Interim dividend per share

8.0c

+166.7% ↑ vs 3.0c

Profit before tax

$70.2m

+46.9% ↑ vs $47.8m

Cash and cash equivalents

$62.9m

-20.8% ↓ vs $79.4m

Total assets

$596.4m

-3.0% ↓ vs $615m

What changed

Tower's HY25 result lifted insurance profitability to unprecedented levels in the supplied four-period baseline

PBT rose 46.9% to NZ$70.2m on revenue growth of 9.8% to NZ$295.8m, taking the PBT margin to 23.7% — above the historical mean of 6.3% and the prior peak of 17.7%. ROE reached 29.0% versus a historical mean of 3.7% and a prior peak of 11.5%. Reported NPAT grew 38.1% to NZ$49.7m, while management's underlying NPAT was NZ$61.7m; the release attributes the NZ$12m gap to customer remediation provisions and Canterbury over-cap claims from the Natural Hazards Commission.

Operating cash flow rose 63.2% to NZ$57.7m and pre-lease FCF reached NZ$47.8m versus NZ$33.7m. The interim dividend climbed to 8 cents per share from 3 cents. Capex rose 498.7% to NZ$9.9m, lifting capex intensity to 3.3% of revenue from 0.6%.

What matters

Underwriting profitability is at a historic peak

The 23.7% PBT margin and 29.0% ROE both sit clear of the prior four-period highs (17.7% and 11.5% respectively). For a general insurer, this points to pricing, claims management and investment income aligning at the same time. The forward question is whether all three can hold.

Reported profit understates the underlying read. Management discloses underlying NPAT of NZ$61.7m versus reported NZ$49.7m, with the bridge attributed to customer remediation provisions and Canterbury over-cap claims. The cleaner economic comparison is underlying NZ$61.7m versus NZ$36.6m a year earlier; the reported PBT growth of 46.9% is the cleanest in-period operating read, given the effective tax rate moved only modestly to 29.1% from 32.2%.

Capital return has outpaced cash generation. The 8 cent interim absorbs 63.0% of pre-lease FCF, above the historical mean of 31.3% and the prior range of 18.2%–41.8%. Payout versus reported NPAT, at 60.6%, is more contained but still well above the 31.6% prior-comparable level — a meaningful step-up alongside the previously flagged return of capital.

Expectations

No FY25 numerical target is supplied

The HY24 first-half share of FY24 revenue and NPAT was 48.5%, suggesting a moderately second-half-weighted pattern; the current half implies an annualised revenue run-rate around NZ$591.6m if that shape repeats. The release flags continuing over-cap claim notifications from the Natural Hazards Commission, which is the live downside in the underlying-to-reported bridge for 2H25.

The data does not include forward written premium, line-by-line claims trends, or reinsurance pricing for FY26, so the durability of the unprecedented margin cannot be tested against forward indicators in this release.

Quality of result

The cash backing is high-grade

OCF of NZ$57.7m exceeds reported NPAT, taking FCF-to-NPAT to 96.1%, and pre-lease FCF of NZ$47.8m sits at the upper edge of the historical range (mean NZ$30.2m). The PBT growth of 46.9% versus NPAT growth of 38.1% — an 8.8pp gap — reflects a moderately higher effective tax rate (29.1% versus 32.2%) rather than below-the-line distortion, so the operating step-up is real.

Two qualifications matter for durability. First, capex rose nearly six-fold to NZ$9.9m, dominated by NZ$9.1m of intangibles; recurring capex intensity is now 3.3% of revenue versus an unusually low 0.6% prior comparable, so the FCF strength partly reflects a low base. Second, the unprecedented margin sits on a benign claims environment and pricing actions whose persistence is not contracted; the customer remediation provision and continuing Canterbury claims are a reminder that prior-period book risk can still surface.

Unresolved

Open questions

What is the expected quantum and tail of further customer remediation provisions, and is the current charge a one-off true-up or a recurring item?
How many additional Canterbury over-cap claims are management modelling for 2H25 and FY25, and what is the gross-versus-reinsured exposure?
Is the NZ$9.1m intangibles capex a discrete programme or a new run-rate that will compress future FCF?
Why is the interim payout absorbing 51.6% of pre-lease FCF when the historical range is 18.2%–41.8%, and how does this interact with the previously flagged return of capital?
What pricing-versus-claims-cost gap is embedded in current premium rates, and is it sustainable into FY26?

This briefing cannot assess underlying claims-cost trends, reinsurance economics, or premium retention, none of which are quantified in the supplied data.

Chat

Ask about TWR HY25

Ask follow-up questions about Tower's HY25 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about TWR HY25

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Tower's HY25 result.

What is the expected quantum and tail of further customer remediation provisions, and is the current charge a one-off true-up or a recurring item?Why does "Underwriting profitability is at a historic peak" matter?How strong was the cash and earnings quality in HY25?What should I watch next for TWR after HY25?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Interim Financial Statements (including Independent Auditor's Review Report)

HY25 / financial report↗

Media Release

HY25 / media release↗

Results Announcement

HY25 / results announcement↗

Results Announcement Presentation

HY25 / results presentation↗

Prior comparable period

Interim Financial Statements (including Independent Auditor's Review Report)

HY24 / financial report↗

Media Release

HY24 / media release↗

Results Announcement

HY24 / results announcement↗

Full-year context

Annual Report (including Financial Statements)

FY24 / financial report↗

Media Release

FY24 / media release↗

Results Announcement

FY24 / results announcement↗

Release context

2025 ASM Investor Presentation

HY25 / commentary↗

Tower Updates FY25 Guidance

HY25 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 8.8pp.

→

Dividend coverage and payout pressure

Dividend payout versus pre-lease FCF is 51.6%, with NPAT payout at 60.6%.

→

Revenue growth context

Revenue growth was 9.8% for this reporting period.

→

ROE and capital efficiency

ROE was 29.0%, +7.4pp versus the prior comparable period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when TWR publishes next

Get the next Tower briefing and related NZX reporting-season updates by email.